Archives
Deferiprone Workflows for Iron-Stress Research
2026-08-11
Deferiprone enables controlled iron depletion without relying on DMSO, making it useful for enterocyte metabolism, cancer biology, and apoptosis induction via iron depletion. This guide translates recent enterocyte findings into practical dose–time designs, iron-repletion controls, and troubleshooting strategies for reproducible experiments.
YTHDF2, m6A Decay, and Hippocampal Memory
2026-08-11
The reference study identifies YTHDF2-mediated degradation of m6A-modified mRNAs as a functional brake on hippocampal synaptic transmission, activity-dependent protein synthesis, and memory. Using conditional genetic manipulation, molecular localization, physiological readouts, and rescue experiments, it connects YTHDF2 and SEMA4B to a causal pathway regulating hippocampus-dependent learning.
Bestatin (Ubenimex): Aminopeptidase Research Guide
2026-08-10
Bestatin, also called Ubenimex, is a research inhibitor with reported activity against several aminopeptidases and selectivity against multiple unrelated proteases. Its applications span aminopeptidase activity measurement, multidrug resistance research, cancer research, and plant chemical genetics, but its potency and biological effects remain assay- and context-dependent.
Chuanxiong Cortex, Pith, and Fenipentol in CHD
2026-08-09
The reference study distinguishes the volatile chemistry of Ligusticum chuanxiong cortex and pith by combining SPME-GC×GC-MS with network pharmacology and molecular docking. Its findings position Fenipentol and related constituents as tissue-associated candidates for mechanistic CHD research, while emphasizing that computational target predictions require experimental validation.
AP20187 for Conditional Gene Control
2026-08-08
AP20187 is a cell-permeable chemical inducer of dimerization for turning engineered signaling circuits on with temporal control. This guide connects reporter assays, regulated cell therapy, metabolic models, and 14-3-3 biology to a practical workflow for formulation, dosing optimization, and troubleshooting.
Ceftolozane Sulfate: From PBP3 to PK/PD
2026-08-07
A translational framework for using Ceftolozane sulfate to connect PBP3 biology, resistance boundaries, susceptibility testing, neutropenic mouse thigh infection models, and exposure-guided antibacterial strategy.
Catalpol (SKU N1352): Reliable Solutions for Cell-Based Assa
2026-08-07
Catalpol (SKU N1352) from APExBIO is a rigorously characterized iridoid glycoside, supporting reproducible cell viability, proliferation, and cytotoxicity assays in neuroprotection, liver fibrosis, and metabolic disease models. This article grounds Catalpol’s value in real laboratory scenarios, evidence-backed protocol guidance, and transparent vendor comparison—empowering biomedical scientists to optimize their experimental outcomes.
DAF-2 Diacetate: Precision Live-Cell Nitric Oxide Imaging Wo
2026-08-06
DAF-2 diacetate (4,5-Diaminofluorescein diacetate) empowers scientists to capture real-time nitric oxide dynamics in live cells, tissues, and whole organisms with nanomolar sensitivity. This article distills best-in-class protocols, troubleshooting strategies, and actionable insights—anchored in recent advances in plant nodule senescence—to accelerate NO pathway research across models.
NHS-Biotin (A8002): Precision Biotinylation for Protein Labe
2026-08-06
NHS-Biotin (N-hydroxysuccinimido biotin) is a gold-standard amine-reactive reagent that enables efficient, stable biotinylation of antibodies and proteins. Its membrane-permeable, short-spacer design supports high-specificity labeling for detection and purification. APExBIO's A8002 formulation is validated for reproducibility in both surface and intracellular protein workflows.
Cy3 Goat Anti-Human IgG (H+L) Antibody in Advanced Immunoass
2026-08-05
The Cy3 Goat Anti-Human IgG (H+L) Antibody streamlines human IgG detection with high sensitivity and flexibility across immunofluorescence, IHC, flow cytometry, and ELISA. Its robust fluorescence and low background enable reproducible results, making it a preferred secondary antibody for translational virology and immunology research.
CTOP: Precision μ-Opioid Receptor Antagonist in Pain Researc
2026-08-05
CTOP enables researchers to unambiguously dissect central μ-opioid receptor signaling, streamlining experimental designs that target opioid-induced hypersensitivity and tolerance. With robust selectivity and a user-friendly solubility profile, CTOP from APExBIO empowers next-generation neuropharmacology studies.
NUAK1/2 Inhibition Lowers Pathogenic Tau in Alzheimer’s Tiss
2026-08-04
Taylor et al. (2023) demonstrate that phosphorylation of tau at serine 356, a pathological hallmark of Alzheimer’s disease, can be selectively reduced in both mouse and human brain tissue using the NUAK1/2 inhibitor WZ4003. This work provides mechanistic evidence for targeting NUAK kinases in tauopathy research and highlights translational differences between model systems.
AR Antagonism Enhances Myeloid-Mediated Tumor Immune Suppres
2026-08-04
Consiglio et al. reveal that enzalutamide, an androgen receptor antagonist, can paradoxically increase tumor progression by enhancing myeloid cell–mediated immune suppression, even in AR-independent cancers. Their mechanistic insights into myeloid cell metabolism reshape our understanding of resistance to androgen deprivation therapy and highlight new considerations for immuno-oncology research.
Electrical Stimulation Enhances Nanoparticle Uptake in Cance
2026-08-03
The reference study demonstrates that alternating current (AC) electrical stimulation significantly increases the endocytosis of magnetic nanoparticles by diverse cancer cell types. This physical approach, acting through macropinocytosis and cytoskeletal modulation, may improve the efficacy of magnetic hyperthermia and MRI-based diagnostics while offering a broadly applicable alternative to chemical surface modifications.
PPP1R3G/PP1γ Regulation of RIPK1 Drives Apoptosis and Necrop
2026-08-03
This study uncovers PPP1R3G as a critical regulator of RIPK1 dephosphorylation, driving apoptosis and necroptosis in response to TNF signaling. The mechanistic insights clarify how distinct phosphorylation states of RIPK1 control cell fate, with broad implications for inflammation research and cancer biology.
754 records 12/51 page Previous Next First page 上5页 1112131415 下5页 Last page